Henry Ford Health System — Detroit, Michigan

Public research footprint of Henry Ford Health System, compiled from the ClinicalTrials.gov public registry.

864

Registered studies

171

Active

Recruiting now

526

Completed

141

Stopped or withdrawn

Most-studied conditions

AChR-Ab Seropositive Generalized Myasthenia Gravis · Generalized Myasthenia Gravis (gMG) · Carcinoma, Renal Cell · Blood Pressure Monitoring

Recently updated registry entries

NCT06910358 — Study of Bitopertin in Participants With EPP or XLP (APOLLO) (Active Not Recruiting)
NCT04737239 — Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild… (Completed)
NCT03765918 — Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Henry Ford Health System?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.